CURIS System Statement of Efficacy Against SARS-CoV-2
CURoxide™ has demonstrated effectiveness against Clostridioides difficile, a spore forming organism, on hard, non-porous surfaces. Spores are the most difficult form of microorganism to kill according to the hierarchy of microorganisms and their resistance to disinfectants. Therefore, CURoxide™ can be used against SARS-CoV-2 when used in accordance with the directions for use against Clostridioides difficile on hard, non-porous surfaces. Refer to the [CDC] [OIE] website at https://www.cdc.gov/coronavirus/ for additional information.
CURIS® System may begin communicating these statement(s) upon notification on the CDC or OIE website www.cdc.gov/outbreaks identified under Section V of the Guidance of an outbreak of an emerging small non-enveloped, large non-enveloped, and/or enveloped viral pathogen. CURIS® System, LLC shall cease and remove all such non-label communications intended for consumers no later than 24 months after the original notification of the outbreak on the CDC or OIE website, unless the agency provides guidance to the contrary due to continued public health concerns. The emerging pathogen claim language may remain on a master label.
To our knowledge, the information in this document is accurate as of 7/16/20. CURIS®System nor any of its affiliates makes any warranty or accepts any liability in connection with the use of this information. This document is intended for the use of technically skilled persons with industry knowledge and training.